|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-10-9
|
|
pubmed:abstractText |
Ciclesonide is a novel inhaled corticosteroid for the treatment of asthma, and it is important to measure the onset of effect of this therapy on airway hyperresponsiveness (AHR), exhaled nitric oxide (NO), and levels of eosinophils in induced sputum.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
134
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
740-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18403668-Administration, Inhalation,
pubmed-meshheading:18403668-Adult,
pubmed-meshheading:18403668-Anti-Allergic Agents,
pubmed-meshheading:18403668-Asthma,
pubmed-meshheading:18403668-Bronchial Hyperreactivity,
pubmed-meshheading:18403668-Bronchial Provocation Tests,
pubmed-meshheading:18403668-Cross-Over Studies,
pubmed-meshheading:18403668-Dose-Response Relationship, Drug,
pubmed-meshheading:18403668-Double-Blind Method,
pubmed-meshheading:18403668-Eosinophils,
pubmed-meshheading:18403668-Female,
pubmed-meshheading:18403668-Humans,
pubmed-meshheading:18403668-Leukocyte Count,
pubmed-meshheading:18403668-Male,
pubmed-meshheading:18403668-Nitric Oxide,
pubmed-meshheading:18403668-Pregnenediones,
pubmed-meshheading:18403668-Sputum
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study.
|
|
pubmed:affiliation |
National Heart and Lung Institute Clinical Studies Unit, Imperial College, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
